Not applicableActive Not RecruitingNCT05227287
What this trial is testing
ADH1 and ADH2 Disease Monitoring Study (DMS)
Who this might be right for
Autosomal Dominant Hypocalcemia
Calcilytix Therapeutics, Inc., a BridgeBio company 95
Showing 20 of 26 results